1. Home
  2. SNTI vs ZAPP Comparison

SNTI vs ZAPP Comparison

Compare SNTI & ZAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • ZAPP
  • Stock Information
  • Founded
  • SNTI 2016
  • ZAPP 2017
  • Country
  • SNTI United States
  • ZAPP Thailand
  • Employees
  • SNTI N/A
  • ZAPP N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • ZAPP Motor Vehicles
  • Sector
  • SNTI Health Care
  • ZAPP Consumer Discretionary
  • Exchange
  • SNTI Nasdaq
  • ZAPP Nasdaq
  • Market Cap
  • SNTI 14.1M
  • ZAPP 13.5M
  • IPO Year
  • SNTI N/A
  • ZAPP N/A
  • Fundamental
  • Price
  • SNTI $2.04
  • ZAPP $2.75
  • Analyst Decision
  • SNTI
  • ZAPP
  • Analyst Count
  • SNTI 0
  • ZAPP 0
  • Target Price
  • SNTI N/A
  • ZAPP N/A
  • AVG Volume (30 Days)
  • SNTI 26.2K
  • ZAPP 94.2K
  • Earning Date
  • SNTI 11-11-2024
  • ZAPP 11-01-2024
  • Dividend Yield
  • SNTI N/A
  • ZAPP N/A
  • EPS Growth
  • SNTI N/A
  • ZAPP N/A
  • EPS
  • SNTI N/A
  • ZAPP N/A
  • Revenue
  • SNTI $338,000.00
  • ZAPP N/A
  • Revenue This Year
  • SNTI $254.47
  • ZAPP N/A
  • Revenue Next Year
  • SNTI $169.66
  • ZAPP $41,300.00
  • P/E Ratio
  • SNTI N/A
  • ZAPP N/A
  • Revenue Growth
  • SNTI N/A
  • ZAPP N/A
  • 52 Week Low
  • SNTI $1.52
  • ZAPP $0.70
  • 52 Week High
  • SNTI $8.48
  • ZAPP $19.10
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 34.51
  • ZAPP 39.34
  • Support Level
  • SNTI $2.00
  • ZAPP $2.56
  • Resistance Level
  • SNTI $2.63
  • ZAPP $2.86
  • Average True Range (ATR)
  • SNTI 0.23
  • ZAPP 0.18
  • MACD
  • SNTI -0.04
  • ZAPP 0.10
  • Stochastic Oscillator
  • SNTI 5.57
  • ZAPP 29.92

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About ZAPP Zapp Electric Vehicles Group Limited

Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories.

Share on Social Networks: